P
Pivot Bio
Fueled by an innovative drive and a deep understanding of the microbiome, Pivot Bio is pioneering game-changing advances in crop nutrition
About Pivot Bio
Pivot Bio is a pioneering startup that addresses the urgent need for sustainable agricultural practices by offering an innovative alternative to synthetic nitrogen fertilizers. The company operates primarily in the agricultural sector, serving farmers across most of the United States. Pivot Bio's core product is a groundbreaking crop nutrition tool that uses naturally occurring microbes to fix nitrogen in cereal crops like corn. This process, known as biological nitrogen fixation, involves converting nitrogen from the air into a form that plants can use, eliminating the need for synthetic fertilizers.
Read full description
The company's business model revolves around selling its microbial nitrogen-fixing products directly to farmers. These products are applied in the field, adhering to the roots of the crops and providing a steady supply of nitrogen throughout the growing season. This method not only enhances crop yields but also mitigates the environmental issues associated with traditional fertilizers, such as leaching, volatilization, and denitrification.
Pivot Bio leverages advanced technologies like machine learning and computational modeling to optimize the performance of its microbial solutions. By continuously improving its products, the company aims to offer farmers more efficient and sustainable ways to meet their crops' nitrogen needs.
Revenue is generated through the sale of these microbial products, which are available as in-furrow applications and soon as seed treatments. The company is also expanding its product pipeline to include more options for different types of crops and farming practices.
In summary, Pivot Bio is transforming agriculture by providing a sustainable, science-based solution to nitrogen fixation, helping farmers increase yields while reducing environmental impact.
At a glance
- Founded
- 2011
- Headquarters
- Minnetonka, United States
- Sector
- Food
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Research & analysis
Latest news
Press, funding announcements and product moves mentioning Pivot Bio.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Bill & Melinda Gates Foundation
DCVC
Monsanto
US National Science Foundation
Series A3 investors entered at this stage
Jenny Rooke
OS Fund
Breakthrough Energy Ventures
Series B and later15 investors entered at this stage
Temasek
Tekfen Ventures
Spruce Capital Partners
Bunge
Alan Cohen
Continental Grain
Pavilion Capital Partners
Prelude Ventures
Codon Capital
Roger Underwood
Rockefeller Asset Management- BVBunge Ventures
Generation Investment Management
G2 Venture Partners- PCPavilion Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
30 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pivot Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pivot Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
